DUBLIN, December 14, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/cgx2f7/gi_stool_testing) has announced the addition of the "GI Stool Testing Market 2015-2019 - Global Market Research" report to their offering.
The global GI stool testing market is expected to grow at a CAGR of 7.37% during 2014-2019
The report, Global GI Stool Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the global BI and analytics platform market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Stool tests are used for the diagnosis of GI disorders and help detect parasite infection, inflammation, bleeding obstruction, and tumors in the GI tract and digestive system. The diagnosis of GI diseases is commonly done through laboratory tests using antigen or culture detection from stool samples. A stool test is of two categories: fecal occult blood test (FOBT) and clinical microbiological stool tests. These tests are either antibody-based or microbial particle-based detection methods, which include immunoassay, CLIA, and molecular diagnostic testing. Stool tests are used for the screening of colorectal cancer as well as the detection of pathogens such as C. difficile, H. pylora, Rotavirus, and Adenovirus.
Point-of-care diagnostic tests for infectious diseases and cancer can be performed at or near the site of patient care. These tests offer patients timely access to care and treatment, reducing the overall probability of disease transmission.
According to the report, many companies are expanding into emerging countries, such as India, China, and Brazil, as these economies have significant growth potential. The implementation of government initiatives to build healthcare infrastructure, increase healthcare budgets, and advance technology propel market growth in these countries.
Further, the report states that gastrointestinal stool tests face stiff competition from their alternatives. Stool tests such as FIT can sometimes give false positive or negative results during colorectal cancer screening. In comparison, colonoscopy and CT colonography tests provide accurate results. For this reason, many medical professionals prefer these procedures to stool tests for the detection of colorectal cancer.
- Clinical Genomics
- Meridian Bioscience
Other prominent vendors
- Beckman Coulter
- Bio-Rad Laboratories
- CARE Products
- EIKEN CHEMICAL
- Epitope Diagnostic
- Exact Sciences
- Helena Laboratories
- Orion Diagnostica
- Pinnacle BioLabs
- Propper Manufacturing
- ScheBo Biotech
- Trinity Biotech
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Reimbursement and coverage: An overview
Part 07: Gastrointestinal stool tests: Present and future technology
Part 08: Market segmentation by product
Part 09: Market segmentation by application
Part 10: Market segmentation by technology
Part 11: Market segmentation by test
Part 12: Geographical segmentation
Part 13: Market drivers
Part 14: Impact of drivers
Part 15: Market challenges
Part 16: Impact of drivers and challenges
Part 17: Market trends
Part 18: Vendor landscape
Part 19: Key vendor analysis
For more information visit http://www.researchandmarkets.com/research/cgx2f7/gi_stool_testing
About Research and Markets:
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
SOURCE Research and Markets